Arch Therapeutics, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On February 3, 2025, Michael S. Abrams, Chief Financial Officer and Treasurer of Arch Therapeutics, Inc. (the “Company”), resigned from his positions with the Company, effective immediately, and has waived any potential rights or claim to any financial obligations under his employment contract.
Effective February 3, 2025, the Company has appointed Terrence W. Norchi, who serves as the Company’s Chief Executive Officer, Chairman, President and Secretary, to the roles of Principal Accounting Officer and Treasurer.
Extracted from this filing and checked against the source text.
Michael S. Abrams resigned as Chief Financial Officer and Treasurer at Arch Therapeutics, Inc..
On February 3, 2025, Michael S. Abrams, Chief Financial Officer and Treasurer of Arch Therapeutics, Inc. (the “Company”), resigned from his positions with the Company, effective immediately, and has waived any potential rights or claim to any financial obligations under his employment contract.View on SEC.gov
Terrence W. Norchi was appointed as Principal Accounting Officer and Treasurer at Arch Therapeutics, Inc..
Effective February 3, 2025, the Company has appointed Terrence W. Norchi, who serves as the Company’s Chief Executive Officer, Chairman, President and Secretary, to the roles of Principal Accounting Officer and Treasurer.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.